STRO
Price
$13.87
Change
-$1.02 (-6.85%)
Updated
Feb 5, 03:37 PM (EDT)
Capitalization
126.85M
35 days until earnings call
Intraday BUY SELL Signals
TRDA
Price
$9.87
Change
-$0.95 (-8.78%)
Updated
Feb 5, 03:54 PM (EDT)
Capitalization
413.15M
41 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

STRO vs TRDA

Header iconSTRO vs TRDA Comparison
Open Charts STRO vs TRDABanner chart's image
Sutro Biopharma
Price$13.87
Change-$1.02 (-6.85%)
Volume$100
Capitalization126.85M
Entrada Therapeutics
Price$9.87
Change-$0.95 (-8.78%)
Volume$200
Capitalization413.15M
STRO vs TRDA Comparison Chart in %
STRO
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
STRO vs. TRDA commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STRO is a Hold and TRDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (STRO: $14.89 vs. TRDA: $10.82)
Brand notoriety: STRO and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STRO: 80% vs. TRDA: 91%
Market capitalization -- STRO: $126.85M vs. TRDA: $413.15M
STRO [@Biotechnology] is valued at $126.85M. TRDA’s [@Biotechnology] market capitalization is $413.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STRO’s FA Score shows that 1 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • STRO’s FA Score: 1 green, 4 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, STRO is a better buy in the long-term than TRDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STRO’s TA Score shows that 2 TA indicator(s) are bullish while TRDA’s TA Score has 1 bullish TA indicator(s).

  • STRO’s TA Score: 2 bullish, 6 bearish.
  • TRDA’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, STRO is a better buy in the short-term than TRDA.

Price Growth

STRO (@Biotechnology) experienced а -4.61% price change this week, while TRDA (@Biotechnology) price change was -2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.81%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was +30.06%.

Reported Earning Dates

STRO is expected to report earnings on Mar 12, 2026.

TRDA is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (-5.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($413M) has a higher market cap than STRO($127M). STRO YTD gains are higher at: 28.695 vs. TRDA (5.253). TRDA has higher annual earnings (EBITDA): -117.36M vs. STRO (-166.43M). TRDA has more cash in the bank: 327M vs. STRO (168M). STRO has less debt than TRDA: STRO (17.7M) vs TRDA (52.4M). STRO has higher revenues than TRDA: STRO (106M) vs TRDA (61.5M).
STROTRDASTRO / TRDA
Capitalization127M413M31%
EBITDA-166.43M-117.36M142%
Gain YTD28.6955.253546%
P/E RatioN/A10.26-
Revenue106M61.5M172%
Total Cash168M327M51%
Total Debt17.7M52.4M34%
FUNDAMENTALS RATINGS
STRO: Fundamental Ratings
STRO
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
STROTRDA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
STRO
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMOGX18.700.16
+0.86%
MassMutual Small Cap Opps Y
FLIAX10.27N/A
N/A
First Sentier American Listed Infras I
JATTX26.45-0.10
-0.38%
Janus Henderson Triton T
MUIGX18.10-0.09
-0.49%
Nationwide BNY Mellon Dyn US Core R6
AFCSX19.39-0.28
-1.42%
American Century Focused Intl Gr I

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been closely correlated with ATOS. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if STRO jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
+0.40%
ATOS - STRO
89%
Closely correlated
-4.34%
CANF - STRO
87%
Closely correlated
-0.25%
PMN - STRO
87%
Closely correlated
-1.57%
PHGE - STRO
87%
Closely correlated
-7.36%
ANL - STRO
81%
Closely correlated
+7.23%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been closely correlated with CGEM. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRDA jumps, then CGEM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-8.23%
CGEM - TRDA
75%
Closely correlated
-6.66%
TERN - TRDA
74%
Closely correlated
-6.39%
STRO - TRDA
74%
Closely correlated
+0.40%
ATOS - TRDA
73%
Closely correlated
-4.34%
ACET - TRDA
72%
Closely correlated
-3.51%
More